Press Releases Aptorum Group Limited

Equities

APM

KYG6096M1226

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-13 pm EDT			5-day change	1st Jan Change
4.5 ^USD	+4.90%		-4.46%	+83.78%

Apr. 30	Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Top Midday Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aptorum : Merger Agreement - Form 6-K	May. 31	PU
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update	Apr. 30	BU
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business	Mar. 06	BU
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023	Dec. 22	BU
Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders	Dec. 21	BU
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023	Nov. 16	BU
Aptorum : Securities Purchase Agreement - Form 6-K	23-09-11	PU
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets	23-08-10	BU
Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma	23-06-22	BU
Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris	23-06-09	BU
Aptorum : Report Of Foreign Private Issuer - Form 6-K	23-05-08	PU
Aptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity Deficiency	23-05-05	BU
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group's Subsidiary Paths Innovations Limited	23-05-02	AQ
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update	23-05-01	AQ
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited	23-05-01	BU
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update	23-04-28	BU
Aptorum : Reports 2022 Fiscal Year End Financial Results and Provides Business Update - Form 6-K	23-04-28	PU
Aptorum : URF Holding Group Limited - Form 6-K	23-03-27	PU
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group	23-03-27	BU
Aptorum Group Announces Completion of End of Phase 1 Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma	23-03-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aptorum Group Limited

Equities

APM

KYG6096M1226

Press Releases

Filters